Pandion Therapeutics Inc. (PAND)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

134 COOLIDGE AVENUE WATERTOWN, MA 02472

Palo Alto Networks, Inc. provides network security solutions. The Company offers firewalls that identify and control applications, scan content to stop threats, prevent data leakage, and offer integrated application, user, and content visibility. Palo Alto provides its products to a range of industries in the international market.

Data as of 2021-05-01 11:39:25 -0400
Market Cap0 Shares Outstanding29.516 Million Avg 30-day Volume0
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low0.0 / 0.0 Next Earnings Date Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PAND instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 75 48 56.25% 29 (1.7%) 17 (0.99%) 70.59%
13F shares: 8.606 Million 10.612 Million -18.9% 4.039 Million 5.886 Million -31.37%
% Ownership 29.1568 35.9484 -18.89% 13.6849 19.9384 -31.36%
New Positions: 40 10 300.0% 22 3 633.33%
Increased Positions 21 20 5.0% 3 7 -57.14%
Closed Positions 13 14 -7.14% 10 9 11.11%
Reduced Positions 9 8 12.5% 4 4 0.0%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PAND (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PAND BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GOYAL VIKAS SEE REMARKS

  • Officer
No longer subject to file 2021-04-01 2

KAKKAR RAHUL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2021-04-01 2

STAGLIANO NANCY

  • Director
No longer subject to file 2021-04-01 1

CARROLL JILL

  • Director
  • 10% Owner
No longer subject to file 2021-04-01 1

SUNDY JOHN CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2021-04-01 2

BELOFF GREGG SEE REMARKS

  • Officer
No longer subject to file 2021-04-01 1

FRAIL DONALD

  • Director
No longer subject to file 2021-04-01 1

VINEY JOANNE L. SEE REMARKS

  • Officer
No longer subject to file 2021-04-01 2

LARSON ERIC D VICE PRESIDENT, FINANCE

  • Officer
No longer subject to file 2021-04-01 2

BECKER DANIEL J.

  • Director
No longer subject to file 2021-04-01 3

CARLO RIZZUTO

  • Director
No longer subject to file 2021-04-01 1

FREEDMAN EDWARD D. CHIEF OPERATING OFFICER

  • Officer
No longer subject to file 2021-04-01 2

FUGLESANG CHRISTOPHER

  • Director
  • 10% Owner
No longer subject to file 2021-04-01 1

CRANE ALAN L

  • Director
  • 10% Owner
No longer subject to file 2021-04-01 1

DORTON KATINA

  • Director
No longer subject to file 2021-04-01 3

MERCK & CO., INC.

MERCK SHARP & DOHME CORP.

  • 10% Owner
0 2021-02-24 1

RA CAPITAL MANAGEMENT, L.P.

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
No longer subject to file 2020-07-21 0

VERSANT VENTURE CAPITAL VI, L.P.

VERSANT VANTAGE I, L.P.

VERSANT VENTURES VI GP, L.P.

VERSANT VENTURES VI GP-GP, LLC

VERSANT VANTAGE I GP, L.P.

VERSANT VANTAGE I GP-GP, LLC

  • 10% Owner
3,754,051 2020-07-21 0

POLARIS PARTNERS GP VIII, L.L.C.

POLARIS ENTREPRENEURS' FUND VIII, L.P.

POLARIS PARTNERS VIII, L.P.

  • 10% Owner
6,366,733 2020-07-21 0

ROCHE HOLDING LTD

ROCHE FINANCE LTD

  • 10% Owner
3,086,084 2020-07-21 0

BOXER CAPITAL, LLC

BOXER ASSET MANAGEMENT INC.

BRASLYN LTD.

LEWIS JOSEPH

DAVIS AARON I.

MVA INVESTORS, LLC

  • 10% Owner
No longer subject to file 2020-07-21 0

MUTZ MITCHELL

  • Director
  • 10% Owner
3,096,084 2020-07-21 0

JDRF T1D FUND LLC

  • 10% Owner
426,333 2020-07-21 0

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
2,248,304 2020-07-17 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP VII LLC

ORBIMED GENESIS GP LLC

  • 10% Owner
0 2020-07-16 0

ACCESS INDUSTRIES HOLDINGS LLC

AI PAN LLC

ACCESS INDUSTRIES MANAGEMENT, LLC

BLAVATNIK LEN

  • 10% Owner
0 2020-07-16 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PANDION THERAPEUTICS INC PAND 2021-04-01 22:15:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 21:45:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 21:15:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 20:45:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 20:15:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 19:45:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 19:15:02 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 18:45:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 18:15:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 17:45:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 17:15:03 UTC -1.0115 1.0615 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 16:45:03 UTC -1.0132 1.0832 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 16:15:03 UTC -1.0132 1.0832 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 15:45:04 UTC -1.0132 1.0832 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 15:15:03 UTC -1.0132 1.0832 100000
PANDION THERAPEUTICS INC PAND 2021-04-01 14:45:03 UTC -1.0132 1.0832 85000
PANDION THERAPEUTICS INC PAND 2021-04-01 14:15:02 UTC -1.0132 1.0832 85000
PANDION THERAPEUTICS INC PAND 2021-04-01 13:45:03 UTC -1.0132 1.0832 85000
PANDION THERAPEUTICS INC PAND 2021-04-01 13:15:02 UTC -1.0132 1.0832 700
PANDION THERAPEUTICS INC PAND 2021-04-01 12:45:03 UTC -1.0132 1.0832 700

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments